Normal view MARC view ISBD view

Array-gain constraint minimum-norm spatial filter with recursively updated gram matrix for biomagnetic source imaging. [electronic resource]

By:

Kumihashi, Isamu

Contributor(s):

Sekihara, Kensuke

Producer: 20101215Description: 1358-65 p. digitalISSN:

1558-2531

Subject(s):

Online resources:

Available from publisher's website

In: IEEE transactions on bio-medical engineering vol. 57

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

861 Plasma Protein Binding Structure-Activity Relationships Related to the N-Terminus of Daptomycin.
by Schneider, Elena K
862 In-vitro activity of ceftriaxone combined with newer agents against MRSA.
by Aktas, Gulseren
863 An in vitro biofilm model of Staphylococcus aureus infection of bone.
by Sweeney, E
864 Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an
by Jahanbakhsh, Seyedehameneh
865 The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
by Shariati, Aref
866 Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
by Van der Auwera, P
867 In vitro activity of LY264826 compared to other glycopeptides and daptomycin.
by Chin, N X
868 Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
by Louie, A
869 Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.
by Antony, Suresh J
870 Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
by Kvirikadze, N
871 An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytes.
by Oleson, F B
872 Recent advances in the treatment of infections due to resistant Staphylococcus aureus.
by Anstead, Gregory M
873 Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis.
by Hidron, Alicia I
874 Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia.
by Cosgrove, Sara E
875 Serious staphylococcal infections--cyclic lipopeptides: meeting new challenges.
by Graninger, W
876 In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
by Dhawan, Benu
877 Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
by Lee, Chen-Hsiang
878 [Effectiveness of daptomycin in the treatment of patients on hemodialysis affected by CVC infection].
by Violi, F
879 Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis.
by Parlato, Ciro
880 Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycin-resistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics.
by Sass, Peter